Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Stock Information for Co-Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Co-Diagnostics Inc.

Co-Diagnostics Reports Full Year 2025 Financial Results
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
Co-Diagnostics to Present at Medical Korea 2026
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro(TM) Instrument

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.